KHANH DUPONT: Open Payments
NPI 1477164572 · EL RENO, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$319 in 15 payments from 11 companies in 2025. Trend: 2023 $162 · 2024 $212 · 2025 $319
Food & beverage: $319
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $63 |
| ABBVIE INC. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Astellas Pharma US Inc | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: FANAPT, VRAYLAR, JARDIANCE, REXULTI, CAPLYTA, Veozah, XIFAXAN, BREZTRI.
Industry payments across OK — which companies pay providers there.
